|
|
|
Volumn 87, Issue 3, 2002, Pages
|
|
What is the dose of STI-571 needed to induce a molecular remission in chronic myeloid leukemia?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
IMATINIB;
MESSENGER RNA;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
CASE REPORT;
CHRONIC MYELOID LEUKEMIA;
DOSE RESPONSE;
GENETICS;
HUMAN;
LETTER;
MALE;
MIDDLE AGED;
REMISSION;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FUSION PROTEINS, BCR-ABL;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
MALE;
MIDDLE AGED;
PIPERAZINES;
PYRIMIDINES;
REMISSION INDUCTION;
RNA, MESSENGER;
|
|
EID: 0036515640
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
